National Drug Code and Regulatory Compliance Management

The contract involves the ongoing management of National Drug Code registration, therapeutic equivalence reporting, FDA compliance, and recall execution for pharmaceutical products supplied under the agreement. This subcontract requires consistent adherence to federal regulatory standards to ensure accurate drug identification, proper labeling, and timely reporting of product equivalence data to support pharmacy substitution and regulatory transparency. The contractor must maintain rigorous control over FDA compliance processes and be prepared to execute recalls swiftly and precisely in accordance with institutional and federal protocols to safeguard public health and supply chain integrity. Work under this agreement is tied to the Department of Defense’s Medical Supply Chain FSGB and falls under NAICS code 541611, indicating a focus on administrative management and other support services related to regulatory affairs. The solicitation was posted on July 13, 2026, with responses due by August 13, 2026, and performance is expected to be coordinated across the broader defense healthcare logistics network without specified geographic limitations. The contractor is expected to demonstrate proven expertise in pharmaceutical regulatory operations and maintain continuous alignment with evolving FDA requirements and Defense logistics standards.